Pages

Saturday, November 2, 2019

Product Recall Alerts: US FDA downplays risk of carcinogen NDMA in already recalled antacid ranitidine

The US FDA had last month issued a safety alert citing traces of NDMA, a known carcinogen, in ranitidine. ... Dr Reddy's Laboratories had also initiated a voluntary recall of the medicine at the retail level in the US on 1 October after ...
Read more: US FDA downplays risk of carcinogen NDMA in already recalled antacid ranitidine